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Background: Advanced age results in crucial alterations of the innate and adaptive immune system leading to
functional defects resulting in infection and chronic diseases. Toll-like receptors (TLR) recognize pathogenic
structures and are important in the immune response to infections and vaccination. However, the role of TLR single
nucleotide polymorphisms (SNP) is poorly understood in the setting of human ageing. This study investigated the
impact of the TLR1 SNPs A743G and T1805G on ageing in different age groups from two European populations.
Results: The TLR1 genotypes 743AA/1805GG (TLR1neg) are associated with a TLR1 negative phenotype, impaired
function and susceptibility to tuberculosis. Carriers of heterozygous 743AG/1805TG and homozygous 743GG/1805TT
genotypes (TLR1pos) have a TLR1 positive phenotype. By comparing healthy young and old German donors, the
old group showed a tendency to carry more TLR1neg and less homozygous TLR1pos genotypes. Anti-inflammatory
Interleukin (IL)-1 receptor antagonist (Ra) was significantly elevated in supernatants of mononuclear cells from old
German subjects with a TLR1pos genotype in contrast to those with the 743AA genotype. Healthy old individuals
and nonagenarians from Italy displayed significantly higher frequencies of TLR1pos genotypes than the old group
from Germany. The data show that tumor-necrosis-factor (TNF)α, CXCL8 and CCL2 levels were higher in old donors
from Germany than in plasma levels from old Italian donors. TNFα and CCL2 levels were significantly raised in old
German individuals compared to Italian nonagenarians. German and Italian donors with the TLR1neg genotype
basically produced more CCL2 than older European donors with TLR1pos genotypes.
Conclusion: The higher frequency of the TLR1pos genotype in elderly Italian subjects may result from different
ethnic populations. Lower inflammatory mediator release of aged Italian individuals is probably due to different
background in nutrition, diet, genetics and to psychological aspects. Elderly donors carrying TLR1pos genotypes
basically release more anti-inflammatory IL-1Ra and less inflammatory CCL2 suggesting a decline of the
pro-inflammatory status found in ageing and, therefore, this may define an anti-inflammatory phenotype. Future
studies are needed to elucidate the association of a TLRpos genotype with decreased susceptibility to infections
and reduced risk to develop artherosclerosis.
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In human ageing, enhanced morbidity and mortality from
infections and declined vaccine responses is reported [1].
This is mainly a consequence of immunosenescence and
the functional impairment of the immune system with age
[1]. Immunosenescence ascribes the acquired dysregulated* Correspondence: LRink@ukaachen.de
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distribution, and reproduction in any mediumimmunity within ageing affecting both innate and adaptive
immunity. Additionally, increased basal levels of inflam-
matory cytokines are observed in old individuals, a condi-
tion which has been termed “inflammageing” [2]. Changes
in numbers and functions of the multiple cell types con-
tribute to the defective innate immunity associated with
ageing. However, less is known about the influence of
human ageing on TLRs, important components of the
innate immune system and sentinels in the recognition of
and response to pathogenic microorganisms.ntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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associated molecular patterns (PAMPS) of bacteria, fungi
and viruses [3,4]. TLR signalling activates a cascade of
molecules resulting in the production the pro-and anti-
inflammatory cytokines/chemokines and the up-regulation
of co-stimulatory molecules. TLRs are differently expressed
on a variety of cells, and build a bridge between innate
and adaptive immunity by activating dendritic cells and
other antigen-presenting cells (APC) [5]. The known
ligands for TLRs are nucleic acids (TLR3, 7–9), recognized
by intracellular located TLRs [6], and triacylated lipo-
peptides (TLR1/2), zymosan (TLR2/6), lipopolysaccharide
(LPS) (TLR4) and flagellin (TLR5) bound by TLRs located
on the cell membrane [7,8].
TLR1/TLR2 heterodimers play an important role in host
defense against mycobacterial infections choosing them
as attractive targets since tuberculosis is increasing in
developed countries with age [9-11]. Within the TLR1
gene, two relevant polymorphisms, the nonsynonymous
SNPs T1805G (I602S, rs5743618) and A743G (S248N,
rs4833095), are described to be related to mycobacter-
ial derived diseases [8,12]. Both SNPs are suggested to
be also associated with leprosy and sepsis [13,14]. Sev-
eral reports demonstrated that TLR1 genotypes 743AA/
1805GG (TLR1neg) are associated with impaired TLR1
cell surface expression and function while heterozygous
743AG/1805TG and homozygous 743GG/1805TT geno-
types (TLR1pos) positively correlate with TLR1 cell sur-
face expression [8,13,15,16].
First studies of TLRs in the context of ageing were per-
formed in mice. TLR1-9 expression and function have been
reported to be generally impaired in macrophages from
aged mice [17]; a functional difference has also been
described. In contrast, others could not confirm changes
in murine TLR2 or TLR4 surface expression but detected
a decrease in pro-inflammatory cytokine production after
stimulation [18]. In human studies, no differences in TLR2
and TLR4 surface expression and LPS stimulated cytokine
production of monocytes between young and old groups
could be observed [19-23]. One group reported that defectsTable 1 Comparison of the frequency of TLR1 genotypes in y
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TG + TT 30in TLR1/2 may result in a higher risk of infection and weak
vaccine response [24,25]. The authors detected that, in
contrast to young subjects, monocytes from old indivi-
duals displayed a lower TLR1 cell surface expression
accompanied by a reduced production of TNFα and IL-
6 and decreased up-regulation of CD80 after specific
TLR1/2 stimulation [25].
Since TLR1 polymorphisms are associated with myco-
bacterial infections and TLR1 surface expression, the
present study was addressed to investigate the influence
of these polymorphisms on human ageing. The frequency
of TLR1 SNPs 743 and 1805 of healthy old German
individuals were compared with young ones and also
investigated in old donors and nonagenarians from Italy.
Furthermore, the impact of TLR1neg and TLR1pos gen-
otypes on basal cytokine and chemokine production of
elderly subjects was examined.
Results
Distribution of TLR1 SNP A743G and SNP T1805G
frequencies in young and old individuals from Germany
In a previous study [8], it has been shown that the
TLR1neg genotype 743AA/1805GG was associated with
higher susceptibility to develop tuberculosis. To determine
whether TLR1 genotypes are correlated with longevity and
ageing, young and old individuals from Germany were ana-
lyzed. A tendency to a decreased homozygous TLR1pos
743GG/1805TT genotype and a higher accumulation of the
TLR1neg genotype 743AA/1805GG in the old German
individuals could be detected (Table 1); though, these
results were statistically not significant (p = 0.097; p = 0.081,
Fisher’s exact test). In summary, these data reveal no evi-
dence for a role of genetic TLR1 variants in ageing and life-
span referred to the German population.
Comparison of the distribution of TLR1 SNP A743G and
SNP T1805G frequencies in elderly individuals from
Germany and Italy
In order to analyze and compare the frequencies of TLR1
genotypes in different European populations (Italian agedoung and old individuals from Germany










Table 2 Comparison of the frequency of TLR1 genotypes in old individuals from Germany (G) and Italy (I)
A. TLR1 A743G genotype Old (G) (n = 101) Old (I) (n = 50) p-value (Fisher’s exact test)
AA 64 13
AG 35 24 0.003
GG 2 13 0.000001
AG + GG 37 37 0.00003
B. TLR1 T1805G genotype Old (G) (n = 101) Old (I) (n = 53) p-value (Fisher’s exact test)
GG 55 10
TG 43 24 0.009
TT 3 19 0.000001
TG + TT 46 43 0.00002
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TLR1pos genotype was noticed in the Italian group
(Table 2). The old donors from Italy predominantly car-
ried the heterozygous TLR1 743AG/1805TG genotype
and displayed only 26% (743AA) and 19% (1805GG)
TLR1neg genotypes. This was in contrast to old German
subjects carrying the TLR1neg genotype more than over
50%. The old group from Italy also revealed significantly
higher frequencies of the homozygous TLR1pos 743GG
and 1805TT (p = 0.000001) genotypes compared to the old
group from Germany (Table 2). The same was detected
when comparing old individuals from Germany and nona-
genarians from Italy (data not shown).
To investigate whether the different distribution among
old individuals in Germany and in Italy resulted from age
or from ethnical differences, the TLR1 SNP A743G geno-
type frequencies of the old persons from Italy (n = 50–53;
age 66–89) to nonagenarians from Italy (n = 31–32; age
90–99) were compared (Table 3). No significant difference
between these two groups (743AG: p = 0.157; 743GG: p =
0.486; Fisher’s exact test) was found. The same result was
derived comparing the same groups in SNP T1805G (TG:
p = 0.164; TT: p = 0.179) (Table 3). This suggests that the
difference between old individuals from Germany and
Italy is a result of different ethnic population characteris-
tics and not of the higher mean age in the Italian group.Table 3 Comparison of the frequency of TLR1 genotypes in o




AG + GG 37




TG + TT 43When the frequencies of these TLR1 genotypes in the
old and a nonagenarian group from Italy were compared,
no significant distributions could be observed. Interest-
ingly, a very similar contribution of SNP A743G and
T1805G was detected in the Italian groups. This observa-
tion has also been described in studies in which compar-
ing different ethnic populations had been compared
[8,15], indicating that both TLR1 SNPs are in linkage
disequilibrium [8,15].Basal cytokine expression of peripheral blood
mononuclear cells (PBMC) isolated from old donors with
TLR1neg 743AA and TLR1pos 743AG genotypes
IL-1Ra is an anti-inflammatory cytokine playing a role in
infectious diseases, in dissolving inflammatory reactions
[26], and in ageing [27]. The basal expression of IL-1Ra,
IL-6 and CXCL8 (IL-8) of PBMC isolated from 4 indivi-
duals with the TLR1neg genotype 743AA and 6 with the
genotype 743AG [8] was measured by ELISA (Figure 1).
These old individuals were participants of the ZINCAGE
study [28]. None of the donors carried the TLR1pos
743GG genotype.
No significant difference in the production of IL-6 and
CXCL8 between the AA and AG genotypes of the SNP 743
could be detected, but IL-1Ra was significantly increased inld and nonagenarian individuals from Italy










Figure 1 Basal IL-1Ra, IL-6 and CXCL8 production of PBMC
from healthy elderly subjects with different TLR1 genotypes.
PBMC isolated from healthy elderly donors with the TLR1neg
genotype 743AA and TLR1pos genotype 743AG were incubated for
72 hours in culture medium, followed by the collection of cell-free
supernatants. IL-1Ra, IL-6 and CXCL8 concentrations were
determined by ELISA. Student’s t-test, two-tailed, p = 0.0031; TLR1
743AA, n = 4, TLR1 743AG, n = 6.
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http://www.immunityageing.com/content/10/1/4old individuals with the TLR1pos genotype AG (Figure 1;
p = 0.031, Student’s t-test).
Comparison of basal cytokine and chemokine production
of aged individuals from Germany and Italy
Aged individuals show increased serum levels of inflam-
matory cytokines (IL-1β, IL-6, TNFα, IL-1Ra) and chemo-
kines such as CXCL8 and CCL2 (MCP-1) [29-35]. TheFigure 2 Plasma levels of cytokines/chemokines derived from old ind
Analyses were performed as described in Methods. Old (G), n = 75-90; old (
statistic test, mean + standard error, *p <0.05; **p < 0.01.analyses of the plasma levels of old individuals from
Germany and Italy as well as from nonagenarians from
Italy revealed that there were no differences in basal IL-6
levels between the different ageing groups (Figure 2A).
Constantly, the old donors from Germany had signifi-
cantly higher levels of basal TNFα, CXCL8, and CCL2
than the old people from Italy, and higher concentrations
of TNFα and CCL2 than the nonagenarians from Italy
(Figure 2B-D). Interestingly, the samples from the nona-
genarian group significantly contained higher CXCL8 but
lower TNFα concentrations than the old groups from
Germany and Italy (Figure 2B, C).
Comparison of basal plasma cytokine and chemokine
levels of aged donors with TLR1neg 743AA/1805GG and
TLR1pos 743AG/1805 T, 743GG/1805TT genotypes
Since higher levels of pro-inflammatory cytokines are
found in aged subjects and TLR1 deficiency is accom-
panied with delayed cytokine production [25,36], it was
examined whether different TLR1 genotypes are asso-
ciated with different plasma cytokine/chemokine levels
in ageing. All old individuals from Germany and Italy
and nonagenarian from Italy were sorted into a TLR1
negative genotype (743AA/1805GG) group, a heterozy-
gous TLR1pos 743AG/1805TG group and a homozygous
TLR1pos 743GG/1805TT group. Next, the basal cyto-
kine and chemokine levels between the different TLR1
genotype groups were analyzed and compared. No differ-
ences in the basal expression of IL-6, TNFα and CXCL8ividuals from Germany and Italy and from Italian nonagenarians.
I), n = 38-40; nonagenarians (I), n = 14-24. G, Germany; I, Italy. Wilcoxon
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(Figure 3A-C). In contrast, circulating levels of CCL2 were
significantly lower in the TLR1pos 743AG/1805TG as well
as in the 743GG/1805TT group compared to the TLR1neg
743AA/1805GG group (Figure 3D). These data indicate
that elderly individuals with a TLR1pos genotype produce
less inflammatory CCL2 which may decrease the activa-
tion and the recruitment of monocytes.
Discussion
The association of TLR polymorphisms with diseases and
greater susceptibility to infections has been reported [37].
As known from many studies, TLR1 is an essential com-
ponent in the defence against Mycobacterium tuberculosis,
Mycobacterium leprae, Borrelia burgdorferi and Neisseria
menigitidis [14,38]. Consequently, a defect in TLR1 ex-
pression and function may result in an impaired im-
mune response against these and other microorganisms
in aged individuals [39]. Since associations of the TLR1
SNP A743G and T1805G with higher susceptibility to
leprosy, tuberculosis and sepsis have been demonstrated
[8,12,13,40], TLR1 polymorphisms may also have clin-
ical implications for aged subjects.
In ageing, defects in TLR1/2 expression and signaling
are potentially associated with higher risk of infection andFigure 3 Comparison of cytokine/chemokine plasma concentrations o
performed as described in Methods. The plasma cytokine concentrations w
(743AA/1805GG), a heterozygous TLR1pos genotype group (743AG/1805GT
TLR1 positives (743AG/1805GT and 743GG/1805TT), statistically compiled fr
(Italy). 743AA/1805GG genotype, n = 66–76; 743AG/1805GT genotype, n = 6
1805TT genotypes, n = 88-89. Wilcoxon statistic test, mean + standard errorpoor vaccine responses, e.g. to influenza [24,39]. Van Duin
et al. [25] reported that after specific TLR1/2 stimulation,
monocytes from older individuals produced half as much
TNFα and IL-6 and displayed a reduced up-regulation of
CD80 than younger ones. In contrast, no differences be-
tween young and old monocytes were found after specific
activation of TLR2/6, TLR4 or TLR5. This defect in TLR1
was accompanied by a 36% lower TLR1 surface expression
in the old subjects compared to young individuals, whereas
TLR2 expression was unchanged [25]. But this study was
restricted to the analysis of one cell type only, and was not
performed under the criteria of SENIEUR, a protocol for
studying healthy aged persons [41]. Surprisingly, questions
or experiences addressing the possibility that low or no
TLR1 surface expression have been resulting from genetic
TLR1 variants were missing, also in follow-up studies [24].
Based on our data [8] and the data presented herein, it
can be hypothesized that the TLR1 SNPs A743G and
T1805G partially account for TLR1 defects observed in
older subjects.
However, the role of TLR polymorphisms in ageing is
incompletely understood. One study examined the TLR4
SNP A896G (D299C), associated with decreased LPS sti-
mulated cytokine synthesis, in subjects with acute myo-
cardial infarction (AMI), young people and centenariansf aged donors with different TLR1 genotypes. Analyses were
ere compared between a homozygous TLR1neg genotype group
), a homozygous TLR1pos genotype group (743GG/1805TT), and all
om old individuals from Germany and Italy and from nonagenarians
5-66; 743GG/1805TT genotype, n = 23; 743AG/1805GT and 743GG/
, *p <0.05; **p < 0.01.
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frequency between patients with AMI and centenarians.
Additionally, the frequency of this polymorphism was
significantly higher in centenarians compared to healthy
young controls. This may indicate that SNPs related to
impaired TLR responsiveness are associated with longev-
ity, but, on contrary, SNPs can also be associated with
higher susceptibility to infections [reviewed in 39].
Our data revealed that genetic variants of TLR1 were
not associated with longevity, but there was a tendency
that old people from Germany more frequently express
the TLR1 negative genotype 743AA/1805GG and less
the homozygous TLR1pos genotype. Further studies
with larger numbers of old and young individuals will fi-
nally define whether a specific TLR1 genotype contri-
butes to larger lifespan or susceptibility to tuberculosis
or not.
It could be shown that PBMC from old German indivi-
duals with the TLR1pos 743AG genotype released signifi-
cantly more anti-inflammatory IL-1Ra than aged individuals
with the TLR1neg 743AA genotype (Figure 1). There are
different reports about the circulating IL-1Ra concentra-
tions in the elderly. The serum/plasma levels of IL-1Ra tend
to be elevated with normal ageing [33,43], others found no
differences between young and old individuals [44]. Ferrucci
and coworkers did not observe a correlation between age
and IL-1Ra after adjusting for cardiovascular risk factors,
additionally [29]. On contrary, it has been reported that
high levels of plasma IL-1Ra, along with IL-6 and C-
reactive protein (CRP), were predictive of higher mortality
in nonagenarians [27]. Our results show evidence that
elevated IL-1Ra levels of old TLR1pos subjects could
dampen the basal pro-inflammatory status of the elderly
by inhibiting the binding of IL-1 to the IL-1 receptor I.
Therefore, this suggests that aged TLR1pos genotype car-
riers are associated with an anti-inflammatory phenotype.
In contrast to young and old German individuals, old
people and nonagenarians from Italy basically carry the
TLR1 positive genotypes, with highest frequency of the
heterozygous 743AG/1805TG genotype. This might be due
to variable TLR1 SNP A743G and T1805G frequencies in
different ethnic populations. European-Americans, African-
Americans, Sub-Saharan-Africans mainly have the homo-
zygous TLR1pos genotype [8,15]. In different European
populations only a very few frequency of the homozygous
TLR1pos genotype can be observed and more than 50%
of the Europeans carry the TLR1neg743AA/1805GG
genotype (National Center of Biotechnology Information
(NCBI), database SNP; Reference SNP cluster reports for
rs4833095 and rs5743618; http://www.ncbi.nlm.nih.gov/
snp/). The cause why variable TLR frequencies exist in
different ethnic populations is not known. Along with
founder effects and migration patterns of ancestors, se-
lective pressures from diseases are discussed [18].Ageing is accompanied by a chronic low-grade inflam-
mation characterized by 2-4-fold increase in serum levels
of inflammatory mediators [31,45], potentially triggering
the onset of age-related inflammatory diseases. TNFα,
CXCL8, and CCL2 plasma levels were found to be lower
in old Italians and nonagenarians than in the plasma of
old Germans (Figure 2). Explanations for this discrepancy
could be: different genetic backgrounds, zinc status, psycho-
logical dimensions (cognitive functions, mood, perceived
stress), body mass index (BMI) and nutritional aspects [46].
Additionally, different diets between German and Italian
donors [47], and different plasma cytokine levels between
ethnic populations [44] may contribute to the observed
varieties in cytokine/chemokine levels.
Plasma levels of TNFα raise with increasing age and
are associated with morbidity and mortality in elderly
populations [34,35]. Nonagenarians from Italy displayed
lower TNFα levels than the other old groups (Figure 2).
That may fit into the results of a study in which increased
T lymphocytes amounts from 81 year old subjects contrib-
ute to elevated TNFα, levels, while centenarians did not
show this altered TNFα secretion profile [48]. Interestingly,
nonagenarians had significantly higher levels of CXCL8 than
old people from Germany and Italy. CXCL8 seems not to
be elevated in the serum of the elderly [49]. Other studies
reported increased levels of CXCL8 and enhanced basal
production by monocytes, which may be responsible for
chronic inflammatory rheumatic diseases in combination
with pro-inflammatory cytokines, [32,50]. These observa-
tions have to be confirmed by other studies to elucidate
whether enhanced CXCL8 leads to larger recruitment of
neutrophils to effectively combat an infection or to
boost the existing low-grade inflammation, additionally.
Aged donors from Italy and Germany with TLR1pos
genotypes had significantly less CCL2 plasma levels than
donors with the TLR1neg genotype (Figure 3D). CCL2
increases during human ageing probably due to dynamic
changes of circulating monocytes [30,51]. Among other
chemokines and chemokine receptors, CCL2 contributes
to the development of artherosclerosis [52], is upregulated
in animal models of mycocardial ischemia and highly
expressed in artherosclerotic lesions. In addition, aged aor-
tic vascular smooth muscle cells (VSMC) basically express
more IL-6, TLR4, and CCL2 than young VSMC in a mur-
ine ex vivo culture system [52,53]. Others described that
increasing CCL2 levels with age are independently asso-
ciated with artherosclerosis [54].
The data indicate that elderly with a TLR1pos genotype
produce lower inflammatory CCL2 which may lead to a
reduced recruitment of monocytes and decreased inflam-
matory conditions. Combined with elevated IL-1Ra, aged
individuals with a TLR1pos genotype may have a lower
risk to develop artherosclerosis, but further studies are
needed to support this hypothesis.
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has been found in aging and in some age-related diseases
[46]. Since ageing and zinc deficiency are characterized
by impaired immune responses, oxidative stress and low
grade chronic inflammation, a relationship between both
states has been hypothesized [46,55]. Additionally, cyto-
kine genes are highly polymorphic and for example the
IL-6 SNP -174 G/C polymorphism appears to be associated
with age-related diseases characterized by an impaired zinc
status [56]. In context with our data, carriers with TLR4
SNP +896 G + genotype expressed lower levels of IL-6 and
TNFα and higher level of anti-inflammatory IL-10 [45].
These cytokines are involved in artherosclerosis and lon-
gevity. Thus, TLR4 SNP +896 G + seems to determine a
minor risk to develop atherosclerosis by decreasing pro-
inflammatory signals and increasing anti-inflammatory
cytokine production [45,57]. Therefore, the TLR1pos
genotype associated with a positive control of inflamma-
tion may also play a protective role against atheroscler-
osis and promote longevity. Inasmuch zinc status and
TLR1 polymorphisms are related to longer lifespan and
control of age-associated diseases have to be shown in
future approaches.
Conclusions
In our study, only a tendency that old German donors
more frequently carry the TLR1neg genotype and less
the TLR1pos homozygous genotype than young subjects
was observed. In contrast, old and nonagenarian indivi-
duals from Italy show significantly higher frequencies for
the TLR1pos genotype indicating a possible lower risk
for mycobacterial infections.
The observation that old and nonagenarian individuals
from Italy produce lower basal levels of TNFα, CXCL8
and CCL2 than aged German donors may be due to dis-
tinct genetics, zinc status, different nutritional and psy-
chological backgrounds.
TLR1pos aged donors show an anti-inflammatory pheno-
type characterized by a higher IL-1Ra production and a
reduced release of CCL2. In combination, these factors
antagonize the pro-inflammatory milieu present in ageing.
In summary, aged individuals with a TLR1pos genotype
may have a reduced risk to develop artherosclerosis, tuber-
culosis and other chronic inflammatory diseases than aged
TLR1neg individuals. Hence, this needs to be proven in
future studies.
Methods
Young and elderly donors
A total of 101 (72 men, 29 women) physically and mentally
healthy volunteers aged 65–82 (mean age of 70.0 years),
were recruited in Aachen, Germany, and designated as the
old group. Aged subjects were drawn from middle class in-
dependently living healthy volunteers between the ages of65 years and 88 years. A detailed questionnaire was used
to exclude any significant illness, i.e. metabolic syndrome
(diabetes/cardiovascular disorders), infections, malignancy.
A second old group (n =53; 26 women, 27 men), consisted
of individuals aged 66–77 (mean age 70.5 years) recruited
from Italy; the third group n = 33 (13 men, 20 women)
were aged 90–99 (mean age 92.8; nonagenarian group)
from Italy as well. The total mean age of all Italian indivi-
duals was 79.3 years. All individuals fulfilled the criteria of
the SENIEUR protocol [8,28,41] and qualification and se-
lection criteria required by the European specific targeted
research project ZINCAGE (www.zincage.org) [28].
The group of young donors consisted of 60 healthy
individuals, (20 men, 40 women), 57 were 22–35 years
old, three individuals out of 60 were 40, 40 and 46 years
old (mean age 29); all were physically and mentally healthy
and did not take any acute or chronically medication for
any disease.
The DNA samples were gained from whole EDTA blood,
fresh or frozen at −20°C, using the Qiagen kit (Hilden,
Germany) according to the manufacturer’s instructions.
Isolated PBMC (peripheral blood mononuclear cells) from
ten physically and mentally healthy elderly volunteers aged
65–82 years from Aachen, Germany, described before [28],
were used for basal expression studies of cytokines.
The circulating concentration of selected chemokines
CCL2, CCL3, CXCL8, and cytokines IL-6 and TNFα were
measured in plasma obtained from groups of healthy old
subjects from Germany and Italy; which were participants
of the ZINCAGE study [32]. The study was approved by
the Ethics committee of the Medical Faculty, RWTH
Aachen University, Germany (EK 061/04 and EK 023/05).
Single nucleotide polymorphism (SNP-) Real-time PCR assay
DNA was extracted from whole blood using the DNAamp
kit (Qiagen, Hilden, Germany). Primers and probes for
the discrimination of TLR1 positives (homozygous GG,
heterozygous AG), and negatives (heterozygous AA) at
position 743 were used and the SNP-PCR assay was
performed as described recently [8] on a 7000 SDS (Ap-
plied Biosystems, Foster City, CA, USA). For SNP detection
of TLR1 T1805G (I602S), a restriction fragment length
polymorphism (RFLP) PCR was performed using the
primer pairs described by Johnson et al. [13] followed
by PstI digestion of the PCR products.
Cytokine expression
CCL2, CXCL8, IL-6 and TNFα were analyzed in plasma
samples of the aged from Germany and Italy and assayed
in multiplex beads assays as described by Mariani et al.
[32]. Culture conditions and stimulation of PBMC from the
ten donors were performed as described previously [28].
For quantification of hIL-1Ra (R&D systems, Wiesbaden,
Germany), hIL-6, hIL-8, antibody sets (all BD Biosciences,
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using an ELISA-plate reader (Sunrise by Tecan Austria,
Salzburg, Austria).
Statistical analysis
Continuous variables are presented as mean and standard
deviation (SD). Categorical data are presented by frequen-
cies and percentages. Associations of alleles with disease
or genotype with disease were represented in 2 × 2 contin-
gency tables and analyzed using Fisher’s exact test.
All tests were two-tailed and assessed at the 5% signifi-
cance level. Because of the exploratory nature of the ana-
lyses, no adjustment was made to the significance level to
account for multiple testing. Analyses were performed as
described [8].
Statistical significance of experimental results (cytokines,
chemokines) was calculated by Student’s t-test and Wilcoxon
signed-rank test using GraphPad Prism version 5.00 for
Windows, GraphPad Software (San Diego, CA, USA).
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